Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dipeptidyl-Peptidase 4 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03951805
What this trial is testing

A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 205
Not applicableStudy completedNCT05313529
What this trial is testing

LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusMild Cognitive Impairment
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 396
Not applicableUnknownNCT05817097
What this trial is testing

Effect of Dipeptidyl-4 Inhibitors in Reducing Stroke Severity, From HIRA Database

Who this might be right for
Cerebral InfarctionInfarction, BrainDipeptidyl-Peptidase IV Inhibitors
Ajou University School of Medicine 22,119
Post-approval studies (Phase 4)Study completedNCT01449747
What this trial is testing

Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
The Catholic University of Korea 24
Testing effectiveness (Phase 2)Study completedNCT00111670
What this trial is testing

DPP-IV Inhibitor in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 291
Large-scale testing (Phase 3)Study completedNCT00575588
What this trial is testing

52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period

Who this might be right for
Type 2 Diabetes
AstraZeneca 891
Post-approval studies (Phase 4)Study completedNCT02607410
What this trial is testing

Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D

Who this might be right for
Type 2 Diabetes Mellitus
University of Sao Paulo General Hospital 40
Large-scale testing (Phase 3)Study completedNCT02946541
What this trial is testing

A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin

Who this might be right for
Type 2 Diabetes Mellitus
Dong-A ST Co., Ltd. 160
Large-scale testing (Phase 3)Ended earlyNCT00958269
What this trial is testing

Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment

Who this might be right for
Type 2 Diabetes MellitusRenal Impairment
Phenomix 360
Not applicableStudy completedNCT02130687
What this trial is testing

Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure

Who this might be right for
Type 2 Diabetes MellitusHypertension
Vanderbilt University 106
Testing effectiveness (Phase 2)Study completedNCT04727580
What this trial is testing

HSK7653 in Chinese Patients with Impaired Glucose Tolerance

Who this might be right for
Impaired Glucose Tolerance
Haisco Pharmaceutical Group Co., Ltd. 99
Early research (Phase 1)Study completedNCT00572650
What this trial is testing

Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired Patients

Who this might be right for
Type 2 Diabetes Mellitus
Novartis 29
Post-approval studies (Phase 4)UnknownNCT03433248
What this trial is testing

Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetES

Who this might be right for
Type2 Diabetes
M.H.H. Kramer 66
Post-approval studies (Phase 4)Study completedNCT02330406
What this trial is testing

Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial

Who this might be right for
Dipeptidyl-Peptidase 4 InhibitorsLDL CholesterolGlycosylated Hemoglobin+2 more
Institute for Clinical Effectiveness, Japan 353
Post-approval studies (Phase 4)Ended earlyNCT02365233
What this trial is testing

Fatty Liver Study in Patients With Type II Diabetes

Who this might be right for
Type II DiabetesNonalcoholic Fatty Liver
The University of Texas Medical Branch, Galveston 5
Testing effectiveness (Phase 2)Study completedNCT03922750
What this trial is testing

A Research Study in People With Type 2 Diabetes to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 154
Post-approval studies (Phase 4)UnknownNCT02386943
What this trial is testing

Study on Exploring the Effect of DPP-4 Inhibitors on β-cell Function by Using the Two-step Hyperglycemic Clamp

Who this might be right for
Type 2 Diabetes
Shanghai Jiao Tong University School of Medicine 12
Not applicableNot Yet RecruitingNCT07460336
What this trial is testing

Effects of Cofrogliptin on Beta-Cell Function in LADA Patients

Who this might be right for
Latent Autoimmune Diabetes in Adults (LADA)
Second Xiangya Hospital of Central South University 84
Post-approval studies (Phase 4)Study completedNCT02106104
What this trial is testing

Renal Effects of DPP-4 Inhibitor Linagliptin in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Amsterdam UMC, location VUmc 48
Post-approval studies (Phase 4)Study completedNCT03983551
What this trial is testing

Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas

Who this might be right for
Type 2 Diabetes MellitusProteinuria
Changhua Christian Hospital 101
Next Page